Prostaplant-F, Weichkapseln

7680663290029 CH-66329 Weichkapseln
Prostaplant-F, Weichkapseln
Prostaplant-F, Weichkapseln
Prostaplant-F, Weichkapseln
1 / 3
google

Article details

Package size
120
Selling units
120
Measure
Kapsel(n)
Galenic form
Weichkapseln
Galenic group
Tabletten

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
21/06/2022
Patient information leaflet
Français
21/06/2022
Patient information leaflet
Italien
21/06/2022
Summary of Product Characteristics
Allemand
21/06/2022
Summary of Product Characteristics
Français
21/06/2022
Summary of Product Characteristics
Italien
21/06/2022

Detailed composition

Substance Quantity Type Category
(N/A)
160.0 MG Substance Wirkstoff (Principe actif)
(N/A)
120.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
- Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance FIMDK
(N/A)
- Substance FTODK
(N/A)
- Substance FTODK

Reimbursement information

Public price
CHF 41.55
Specialties list
Yes
Generic
No
SL addition date: 01/05/2018

Authorization holder

Schwabe Pharma AG

6403 Küssnacht am Rigi

Authorization information

Swissmedic authorization number
66329
Drug name
Prostaplant-F, Weichkapseln
Galenic form
KAPWE
ATC Code
G04CX02
Authorization status
Z
Dispensing category
B
First authorization
21/12/2016
Authorization expiration date
31/12/9999
IT Number
05.98.0.
Domain
Human medicine
Field of application
Zur Linderung von Beschwerden infolge benigner Prostatahyperplasie

Package details

Description (FR)
PROSTAPLANT F caps moll 120 pce
Description (DE)
PROSTAPLANT F Weichkaps 120 Stk
Market launch
21/12/2016
Narcotic (BTM)
No

Other package sizes (1)

PROSTAPLANT F caps moll 60 pce
60 KAP
GTIN: 7680663290012
View